Literature DB >> 17268772

Neuronal imaging using SPECT.

Shohei Yamashina1, Jun-ichi Yamazaki.   

Abstract

BACKGROUND: 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is one of only a few methods available for objective evaluation of cardiac sympathetic function at a clinical level. Disorders in cardiac sympathetic function play an important role in various heart diseases, and MIBG provides an abundance of useful information for evaluation of disease severity, prognosis, and therapeutic effects; this information is of particular value in patients with heart failure, ischemic heart diseases, or arrhythmic disorders. On the other hand, the quantitative indices for MIBG differ between institutions, and evidence has not been sufficiently well established for MIBG, compared with myocardial perfusion imaging, in ischemic heart diseases. REVIEW: In view of these difficulties, this review provides fundamental information regarding MIBG, its usefulness for various diseases and future difficulties.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17268772     DOI： 10.1007/s00259-006-0359-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


  88 in total

1.  Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients.

Authors:  Satoru Ohshima; Satoshi Isobe; Hideo Izawa; Mamoru Nanasato; Akitada Ando; Akira Yamada; Kiyoyasu Yamada; Tomoko S Kato; Koji Obata; Akiko Noda; Takao Nishizawa; Katsuhiko Kato; Kohzo Nagata; Kenji Okumura; Toyoaki Murohara; Mitsuhiro Yokota
Journal:  J Am Coll Cardiol       Date:  2005-11-04       Impact factor: 24.094

2.  Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.

Authors:  D Agostini; A Belin; M H Amar; Y Darlas; M Hamon; G Grollier; J C Potier; G Bouvard
Journal:  J Nucl Med       Date:  2000-05       Impact factor: 10.057

3.  Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.

Authors:  U Lotze; S Kaepplinger; A Kober; B M Richartz; D Gottschild; H R Figulla
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

4.  Cardiac adrenergic denervation in patients with non-Q-wave versus Q-wave myocardial infarction.

Authors:  S Simula; T Lakka; T Laitinen; J Remes; R Kettunen; J Kuikka; J Hartikainen
Journal:  Eur J Nucl Med       Date:  2000-07

5.  Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.

Authors:  M Suwa; Y Otake; A Moriguchi; T Ito; Y Hirota; K Kawamura; I Adachi; I Narabayashi
Journal:  Am Heart J       Date:  1997-03       Impact factor: 4.749

6.  Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2003-06       Impact factor: 10.057

Review 7.  Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.

Authors:  Junichi Taki; Mitsuhiro Yoshita; Masahito Yamada; Norihisa Tonami
Journal:  Ann Nucl Med       Date:  2004-09       Impact factor: 2.668

8.  Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy.

Authors:  J Schofer; R Spielmann; A Schuchert; K Weber; M Schlüter
Journal:  J Am Coll Cardiol       Date:  1988-11       Impact factor: 24.094

9.  Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.

Authors:  M C Tobes; S Jaques; D M Wieland; J C Sisson
Journal:  J Nucl Med       Date:  1985-08       Impact factor: 10.057

10.  Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.

Authors:  D M Wieland; J Wu; L E Brown; T J Mangner; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1980-04       Impact factor: 10.057
View more
  18 in total

1.  Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.

Authors:  Berlinda J van der Veen; Imad Al Younis; Albert de Roos; Marcel P M Stokkel
Journal:  J Nucl Cardiol       Date:  2012-06-06       Impact factor: 5.952

Review 2.  The role of radionuclide imaging in heart failure.

Authors:  Vinay Gulati; Gilbert Ching; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

3.  Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images.

Authors:  Arnold F Jacobson; Dale T Matsuoka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-29       Impact factor: 9.236

4.  123I-MIBG imaging detects cardiac involvement and predicts cardiac events in Churg-Strauss syndrome.

Authors:  Yoriko Horiguchi; Yukiko Morita; Naomi Tsurikisawa; Kazuo Akiyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-23       Impact factor: 9.236

Review 5.  MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.

Authors:  Giorgio Treglia; Ernesto Cason; Antonella Stefanelli; Fabrizio Cocciolillo; Daniela Di Giuda; Giorgio Fagioli; Alessandro Giordano
Journal:  Clin Auton Res       Date:  2011-07-27       Impact factor: 4.435

Review 6.  Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.

Authors:  Giorgio Treglia; Ernesto Cason; Anna Gabellini; Alessandro Giordano; Giorgio Fagioli
Journal:  Neurol Sci       Date:  2010-03-10       Impact factor: 3.307

7.  Amnestic mild cognitive impairment with low myocardial metaiodobenzylguanidine uptake.

Authors:  Ryuji Sakakibara; Takeshi Ogata; Masayuki Haruta; Masahiko Kishi; Yohei Tsuyusaki; Akihiko Tateno; Fuyuki Tateno; Takayuki Mouri
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

8.  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.

Authors:  Shinro Matsuo; Kenichi Nakajima; Koichi Okuda; Masaya Kawano; Takehiro Ishikawa; Tetsuo Hosoya; Junichi Taki; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-07       Impact factor: 9.236

9.  Impact of age on myocardial uptake of ¹²³I-mIBG in older adult subjects without coronary heart disease.

Authors:  Arnold F Jacobson; Ji Chen; Liudmilla Verdes; Russell D Folks; Daya N Manatunga; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2013-03-13       Impact factor: 5.952

10.  Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Hui-Ling Li; Mitsuharu Kawamura; Taku Asano; Kaoru Tanno; Akira Shinozuka; Takehiko Gokan; Youichi Kobayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-12       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.